Status asthmaticus questions are built to punish reflex thinking. The vignette looks like “just asthma,” but the exam is really testing whether you recognize impending respiratory failure, know what to do next, and can explain why the tempting distractors are wrong.
Tag: Pulmonary > Obstructive Lung Disease
The Vignette (Q-bank style)
A 22-year-old woman with a history of asthma is brought to the ED for severe shortness of breath and wheezing. She has used her albuterol inhaler repeatedly without relief. She is sitting upright, speaking in single words. Vitals: T 37°C, HR 132, RR 34, BP 128/76, SpO₂ 91% on room air. Exam shows accessory muscle use and diffuse wheezing. Peak expiratory flow is 35% of predicted. She receives nebulized albuterol and ipratropium plus IV corticosteroids. Thirty minutes later, she is more fatigued, and wheezing is now barely audible. ABG shows pH 7.28, PaCO₂ 52 mm Hg, PaO₂ 68 mm Hg.
Question: What is the next best step in management?
Answer choices
A. Administer IV magnesium sulfate
B. Administer IV propranolol
C. Start inhaled fluticasone
D. Give IV furosemide
E. Provide endotracheal intubation and mechanical ventilation
Step 1: Identify the Diagnosis and the “Danger Clue”
This is status asthmaticus: a severe asthma exacerbation that is refractory to initial bronchodilator therapy.
The question’s real pivot is the change from loud wheezing to “barely audible” wheeze plus rising CO₂.
High-yield danger signs of impending respiratory failure in asthma
- Normalizing or rising PaCO₂ (especially after previously low PaCO₂)
- Early asthma: hyperventilation → low PaCO₂ (respiratory alkalosis)
- Decompensation: fatigue + air trapping → high PaCO₂ (respiratory acidosis)
- Silent chest (little/no wheeze) = minimal airflow, not improvement
- Altered mental status, exhaustion, inability to speak full sentences
- Persistent hypoxemia despite oxygen and bronchodilators
- Peak flow/FEV₁ <40% predicted (severe); <25% (life-threatening)
Correct Answer: E. Endotracheal intubation and mechanical ventilation
She has hypercapnic respiratory failure (pH 7.28, PaCO₂ 52) with clinical fatigue and a “quiet chest.” This is not the moment to add another adjunct and hope—this is the moment to secure the airway and ventilate.
What the test wants you to know about ventilating asthmatics
Mechanical ventilation can be tricky because asthma causes air trapping and dynamic hyperinflation (auto-PEEP), increasing risk of:
- Barotrauma (pneumothorax)
- Hypotension (decreased venous return)
Ventilator strategy (conceptual)
- Lower respiratory rate, allow prolonged expiration
- Lower tidal volumes, permissive hypercapnia may be acceptable
- Watch for auto-PEEP and rising plateau pressures
Core treatment stack for severe exacerbation (what’s already happening here)
- Short-acting β₂ agonist (albuterol) + ipratropium
- Systemic corticosteroids (IV/PO)
- Oxygen to target adequate saturation
- Consider magnesium sulfate in severe cases if not yet failing
But once you see rising CO₂ + fatigue/silent chest, the “next best step” is airway support.
Why Every Distractor Matters (and why it’s wrong here)
A. Administer IV magnesium sulfate
Why it’s tempting: Magnesium relaxes smooth muscle; it’s a classic add-on for severe asthma.
When it’s right: Severe exacerbation with poor response to initial therapy but without clear respiratory failure.
Why it’s wrong here: This patient has already decompensated (hypercapnia + acidosis + fatigue + near-silent chest). Magnesium can be helpful, but it does not replace ventilatory support when the patient is failing.
USMLE pearl: In asthma, a rising PaCO₂ is a late, ominous sign. At that point, escalation is about ventilation, not “one more bronchodilator adjunct.”
B. Administer IV propranolol
Why it’s tempting: Some students misassociate tachycardia with “treat with a beta-blocker.”
Why it’s wrong: Propranolol is a nonselective β-blocker, which blocks β₂ receptors → bronchoconstriction and can precipitate/worsen asthma exacerbations.
High-yield:
- Nonselective β-blockers (e.g., propranolol, nadolol) are generally contraindicated in asthma.
- Even β₁-selective agents can be risky at higher doses.
C. Start inhaled fluticasone
Why it’s tempting: Inhaled corticosteroids (ICS) are the cornerstone of long-term asthma control.
Why it’s wrong: ICS is controller therapy, not acute rescue. In status asthmaticus, you need rapid bronchodilation and systemic steroids; this patient also needs ventilatory support.
Exam framing:
- Acute: SABA ± ipratropium + systemic steroids ± Mg
- Chronic: ICS (like fluticasone), LABA/ICS combos, leukotriene modifiers, biologics
D. Give IV furosemide
Why it’s tempting: Dyspnea + hypoxemia sometimes triggers “treat pulmonary edema.”
Why it’s wrong: This vignette screams asthma: wheeze, low peak flow, accessory muscle use, refractory symptoms. Furosemide treats volume overload (e.g., CHF with pulmonary edema), not bronchospasm. It could worsen dehydration, thicken secretions, and delay proper care.
How CHF would look different:
- Crackles > wheezing (though “cardiac asthma” can wheeze)
- S3, JVP elevation, peripheral edema, cardiomegaly, Kerley B lines
- Often older patient with cardiac history
Key Takeaways: Status Asthmaticus in One Table
| Feature | Early/Compensated Exacerbation | Impending Respiratory Failure |
|---|---|---|
| Work of breathing | Increased | Exhaustion/fatigue |
| Wheeze | Loud/diffuse | Decreased/absent (“silent chest”) |
| PaCO₂ | Low (hyperventilation) | Normal/high (hypoventilation) |
| pH | Respiratory alkalosis | Respiratory acidosis |
| Next step | Bronchodilators + systemic steroids ± Mg | Intubation/ventilation |
Rapid-Fire High-Yield Facts (USMLE gold)
- Asthma is obstructive: decreased with increased RV and air trapping.
- “Quiet chest” is bad in asthma—means minimal airflow, not improvement.
- Rising PaCO₂ during an asthma attack is a red flag for impending failure.
- Initial therapy: inhaled SABA + ipratropium + systemic steroids; oxygen as needed.
- Adjunct: IV magnesium sulfate for severe, refractory bronchospasm (before failure).
- Avoid: nonselective β-blockers (propranolol) and sedatives that suppress respiratory drive unless you are controlling the airway.
- Ventilation strategy: avoid breath stacking—allow long expiration to prevent auto-PEEP.
How to Think Like the Test Writer
If the vignette gives you:
- Single-word sentences
- Accessory muscle use
- PEF <40%
- No improvement after nebs + steroids
- Silent chest + high PaCO₂
…the question isn’t “what’s another asthma med?” It’s: Who needs a tube?